BACKGROUND: Hemorrhagic shock increases the hypnotic effect of propofol, but the influence of hemorrhagic shock on the immobilizing effect of propofol is not fully defined. METHODS: Twenty-four swine (30.3 Ϯ 3.6 kg) were anesthetized by inhalation of isoflurane and randomly assigned to either a control (n ϭ 12) or a hemorrhagic shock (n ϭ 12) group. Animals in the shock group were bled to a mean arterial blood pressure of 50 mm Hg and maintained at this level for 60 min. After isoflurane inhalation was stopped, propofol was infused at 50 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 until no movement was observed after application of a dewclaw clamp every 2 min. Arterial samples for measurement of the propofol concentration were collected just before each use of the dewclaw clamp and the Bispectral Index (BIS) was also recorded. Analysis of the pharmacodynamics was performed using a sigmoidal inhibitory maximal effect model for BIS versus effect-site concentration and a logistic regression analysis for the probability of movement versus effect-site concentration. RESULTS: The propofol doses needed to reach a 50% decrease from baseline BIS, and no movement after noxious stimuli were reduced by hemorrhagic shock by 54% and 38%, respectively. Hemorrhagic shock decreased the effect-site concentration that produced 50% of the maximal BIS effect from 11.6 Ϯ 3.8 to 9.1 Ϯ 1.7 g/mL and that producing a 50% probability of movement from 26.8 Ϯ 1.0 to 20.6 Ϯ 1.0 g/mL. CONCLUSIONS: The results show that hemorrhagic shock increases both the hypnotic and immobilizing effects of propofol due to pharmacokinetic and pharmacodynamic alterations, with the changes in pharmacodynamics occurring to a similar extent for both effects.
Yoriko Morishima, PhD † Masahiro Uraoka, MD* Takasumi Katoh, MD* Shigehito Sato, MD* BACKGROUND: Hemorrhagic shock increases the hypnotic effect of propofol, but the influence of hemorrhagic shock on the immobilizing effect of propofol is not fully defined. METHODS: Twenty-four swine (30.3 Ϯ 3.6 kg) were anesthetized by inhalation of isoflurane and randomly assigned to either a control (n ϭ 12) or a hemorrhagic shock (n ϭ 12) group. Animals in the shock group were bled to a mean arterial blood pressure of 50 mm Hg and maintained at this level for 60 min. After isoflurane inhalation was stopped, propofol was infused at 50 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 until no movement was observed after application of a dewclaw clamp every 2 min. Arterial samples for measurement of the propofol concentration were collected just before each use of the dewclaw clamp and the Bispectral Index (BIS) was also recorded. Analysis of the pharmacodynamics was performed using a sigmoidal inhibitory maximal effect model for BIS versus effect-site concentration and a logistic regression analysis for the probability of movement versus effect-site concentration. RESULTS: The propofol doses needed to reach a 50% decrease from baseline BIS, and no movement after noxious stimuli were reduced by hemorrhagic shock by 54% and 38%, respectively. Hemorrhagic shock decreased the effect-site concentration that produced 50% of the maximal BIS effect from 11.6 Ϯ 3.8 to 9.1 Ϯ 1.7 g/mL and that producing a 50% probability of movement from 26.8 Ϯ 1.0 to 20.6 Ϯ 1.0 g/mL. CONCLUSIONS: The results show that hemorrhagic shock increases both the hypnotic and immobilizing effects of propofol due to pharmacokinetic and pharmacodynamic alterations, with the changes in pharmacodynamics occurring to a similar extent for both effects. Hemorrhagi c shock increases the effect of several classes of IV anesthetics because of pharmacokinetic and pharmacodynamic changes, [1] [2] [3] [4] [5] and such changes sometimes complicate the management of patients who have significant blood loss before or during surgery. 6 Previous reports have shown that an increased electroencephalographic (EEG) effect of propofol occurs during hemorrhagic shock 7, 8 ; however, the EEG only reflects the influence on hypnosis, and not the immobilizing effect, which is also of importance for defining the potency of an anesthetic. The motor response to a noxious stimulus is primarily mediated by subcortical structures, especially those in the spinal cord, 9, 10 and EEG parameters do not directly reflect the activity of these structures. In fact, in contrast to our previous finding that hemorrhagic shock minimally alters the EEG effect of inhaled anesthetics, 11, 12 hemorrhagic shock decreases the anesthetic minimum alveolar anesthetic concentration (MAC) 13, 14 ; therefore, alterations in anesthetic potency in response to hemorrhage differ at anesthetic sites of action for production of hypnosis and immobility. The clinical implications of our previous studies are that hemorrhagic shock increases the threshold for movement in response to noxious stimuli and that it is straightforward to obtain immobility using inhaled anesthetics, even though hypnotic potency does not change in a comparable manner. A high concentration of propofol produces immobilization in response to noxious stimuli 15 and hemorrhagic shock induces a high concentration, but it is unclear whether hemorrhagic shock will increase the immobilizing effect of propofol in a manner similar to that seen for inhaled anesthetics.
We conducted the present study to examine the influence of hemorrhagic shock on the hypnotic and immobilizing effects of propofol at the same time, because this allows a comparison of the extent of change in each effect. We hypothesized that hemorrhagic shock would increase the hypnotic and immobilizing effects of propofol.
METHODS

Animal Preparation
This study was approved by the Committee on Animal Research, Hamamatsu University School of Medicine, Hamamatsu, Japan. Twenty-four pigs (both male and female, 3-mo old and infection free, body weight range: 24.4 -39.1 kg, mean Ϯ sd ϭ 30.3 Ϯ 3.6 kg) were used in the study. General anesthesia was induced by isoflurane inhalation (5%) in oxygen at 6 L/min using a standard animal mask. After tracheostomy, the lungs of the pigs were mechanically ventilated and anesthesia was maintained with a 2% end-tidal concentration of isoflurane in an oxygen-air mixture (oxygen:air ϭ 3:3 L/min). The tidal volume was initially set to approximately 10 mL/kg, and the ventilation rate was 25 breaths/min. Expiratory gases were analyzed using a Capnomac Ultima (ULT-V-31-04, Datex-Ohmeda, Helsinki, Finland). The ventilator was adjusted to keep the end-tidal carbon dioxide between 35 and 45 mm Hg during the preparation period, and this setting was maintained throughout the study. Lead II of an electrocardiogram was monitored using three cutaneous electrodes. A pulmonary artery catheter (5F, 4 lumen, Nihon Kohden, Tokyo, Japan) and a central venous catheter (16 gauge) were inserted via the right jugular vein, and arterial catheters (16 gauge) were placed in the bilateral femoral arteries. Heparin (100 U/kg) was administered every 30 min after animal preparation until the end of the study. The blood temperature of the pigs was maintained between 39.0°C and 40.0°C (normothermia for pig). After these preparation steps, EEG monitoring was started by preparing the skin over the frontooccipital regions bilaterally and positioning four cutaneous electrodes (Zipprep, Aspect Medical Systems, Natick, MA). Four channels of the EEG were amplified and digitally recorded using an Aspect A-1000 EEG instrument with version 3.0 software (Aspect Medical Systems, Natick, MA). The low-pass and high-pass filters were set at 2 and 70 Hz, respectively. Processed EEG values (Bispectral Index [BIS], 95% spectral edge frequency, and median frequency) were collected electronically at intervals of 5 s.
Experimental Protocol
After completion of animal preparation, animals were assigned randomly to a control group (n ϭ 12) or a hemorrhagic shock group (n ϭ 12). Our protocol included use of an isobaric hemorrhagic model, 4, 7 which was designed to ensure an equivalent degree of metabolic compromise from hemorrhagic shock in each animal before initiation of the noxious stimulus.
Each animal was bled via an arterial catheter, and the blood was stored in a beaker surrounded by warm water to maintain normothermia. Mean arterial blood pressure (MAP) values were monitored continuously via the other arterial catheter, and blood was removed at a rate required to achieve a linear decrease in MAP to 50 mm Hg over a 20-min period. Blood was then removed or reinfused to maintain a MAP of 50 mm Hg for a 60-min period. The control animals underwent an 80-min sham hemorrhage period. Baseline measurements were taken after completion of animal preparation and then inhalation of isoflurane was stopped. The start of propofol infusion was delayed as long as possible until observation of spontaneous movement. After confirming spontaneous movement (at which time the end-tidal isoflurane concentration had decreased to Ͻ0.5% in all animals), propofol was administered continuously at a rate of 50 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 via a central venous catheter. In a pilot study, no movement in response to a noxious stimulus was obtained in any animals at this propofol infusion rate. Arterial blood samples (2 mL) were taken every 2 min after the start of propofol infusion to determine the plasma concentrations of propofol. After confirming that the BIS value had decreased by more than 50% from baseline, a supramaximal pain stimulus was performed just after each blood sampling by application of a clamp to the dewclaw for up to 30 s or until movement was observed, and the presence or absence of a withdrawal reaction was recorded. A positive reaction was defined either as a withdrawal of the clamped foot or as a gross movement of another leg or the head. All points before the BIS had decreased by more than 50% were dealt with as a positive reaction. Propofol infusion was terminated at the next blood sampling time after no movement was observed. The dewclaw clamp procedure was repeated until a return of movement was observed, and all points after a return of movement were dealt with as a positive reaction. Arterial blood samples were collected every 2 min until spontaneous movement was observed. Propofol concentrations were assayed by high performance liquid chromatography, according to the method of Plummer. 16 The lower limit of detection was 15 ng/mL and the mean intraassay coefficient of variation was 7.2%. Hematocrit, lactate, and arterial blood gases were measured and heart rate, MAP, mean pulmonary arterial pressure, central venous pressure, and cardiac output (CO) were recorded at the completion of hemorrhagic shock or after the sham hemorrhage period. CO was determined with a thermodilution computer (Cardiac Output Computer, MTC6210, Nihon Kohden, Tokyo, Japan) using injection of 5 mL of cold 5% glucose into the right atrium. For each condition, CO measurements were made four times, and the mean of the last three values was recorded as the CO.
Pharmacokinetic Analysis
The pharmacokinetics of propofol were quantified and a two-or three-compartment model using the propofol concentration versus time data was used to estimate pharmacokinetic parameters for each animal. 17 The propofol concentration in the central compartment (C 1 ) is described by the differential equation
in which C 2 and V 2 are the concentration and distribution volume in the rapid peripheral compartment, C 3 and V 3 are those in the slow peripheral compartment (three-compartment model), or dC 1 /dt ϭ Ϫ(k 12 ϩ k 10 ) C 1 ϩ k 21 C 2 V 2 /V 1 ϩ R, in which C 2 and V 2 are the concentration and distribution volume in the peripheral compartment (twocompartment model), k ij is the rate constant for transfer from the i-th compartment to the j-th compartment, k 10 is the elimination constant from the central compartment to outside the body, and R is the influx rate constant from outside the body to the central compartment. R should be the infusion rate during propofol infusion and should be zero after discontinuation of propofol. These micropharmacokinetic parameters were fitted to the measured propofol concentrationtime profile by least-squares regression using the Solver tool in Microsoft Excel (Microsoft Excel 2000, Microsoft Corporation, Redmond, WA). After fitting to a two-and three-compartment model, we calculated the coefficient of determination (r 2 ) as an objective function, 18 as described previously, 11, 12 and the better-fit model was chosen.
Pharmacodynamic Analysis of the Hypnotic Effect
The hypnotic effect was characterized by examining the influence of propofol on the BIS. Several studies have demonstrated that the BIS is useful for predicting changes in anesthetic depth of inhaled anesthetics in pigs. 19, 20 In our pilot studies, BIS values decreased or increased with an increasing or decreasing propofol dose, respectively, also allowing adequate evaluation of the effect of propofol, and therefore, we chose to use BIS for this purpose, as in other propofol studies in pigs. 4, 7 The BIS was related to the effect-site concentration (C e ), which was derived from the classic first-order decay of the plasma propofol concentration (C p ): dC e /dt ϭ k e0 (C p Ϫ C e ), where k e0 is the elimination constant from the effect site and determines the equilibration between C p and C e . The k e0 value was calculated for each animal using nonlinear leastsquares fitting, and optimization of k e0 was accomplished using the Solver tool in Excel by minimizing the area bounded by the hysteresis loop plotted between the BIS values every 2 min and the C p values at the respective times. Because plots of the concentration-EEG effect relationship were sigmoidal, an inhibitory sigmoid E max equation (Hill equation 21 ) was used to model the relationship parametrically. The
predicted effect, E 0 is the baseline effect, E max is the maximal effect, EC 50 is the effect-site concentration that produces 50% of the maximal effect, and ␥ is a measure of curve steepness, which was used to fit the equation to data for an individual animal. The parameters in the model were estimated using nonlinear least-squares fitting in Excel, through optimization with the Solver tool to minimize the sum of squares between the estimated and measured BIS values. We also report the coefficient of determination (r 2 ), as described previously. 11, 12 Pharmacodynamic Analysis of the Immobilizing Effect
The immobilizing effect in response to a noxious stimulus was characterized by examining the presence or absence of movement after application of a dewclaw clamp. The response (movement ϭ 1, no movement ϭ 0) was related to the effect-site concentration (C e ), which was derived from the classic first-order decay of the plasma propofol concentration (C p ): dC e /dt ϭ k e0-immobility (C p Ϫ C e ). The k e0-immobility value was calculated for each animal, and optimization of k e0-immobility was accomplished by minimizing the area bounded by the hysteresis loop plotted between the response every 2 min and the C p values at the respective times ( Figs. 3A  and B ). Using all animal plots for the response and effect-site propofol concentration in each state, logistic regression analysis was used to determine the relationship between the probability of movement and the effect-site propofol concentration, and the effect-site concentration that produced a 50% probability of movement (EC 50-immobility ) was calculated.
Statistical Analysis
Data are expressed as mean values Ϯ sd. Hematocrit, lactate, arterial blood gas analysis, and hemodynamic, pharmacokinetic, and pharmacodynamic variables for each state were analyzed using unpaired t-tests. P values Ͻ0.05 were considered to be statistically significant.
RESULTS
The average volume of blood withdrawn was 833 Ϯ 154 mL (26.7 Ϯ 3.6 mL/kg) after maintenance of the isobaric hemorrhagic shock model for 60 min. The averaged hemodynamic and metabolic variables in each state are shown in Table 1 . Heart rate, lactate, and hematocrit in animals in the hemorrhagic shock group were significantly higher and MAP, central venous pressure, CO, pH, and base excess were significantly lower compared with those in the control group. The higher hematocrit in the hemorrhagic shock group may have been due to autotransfusion from the spleen and/or splanchnic perfusion. The same phenomenon was observed in our previous studies after withdrawal of blood without fluid infusion. 11, 14 Individual plasma concentration versus time profiles of propofol in both groups are shown in Figure 1 . In the hemorrhagic shock group, the total infusion dose (401 Ϯ 176 mg) was significantly lower than that in the control group (974 Ϯ 269 mg), and the mean duration of infusion (16 Ϯ 8 min) was significantly shorter than in the control group (40 Ϯ 11 min); however, the peak plasma propofol concentrations did not differ between the groups (28.0 Ϯ 6.2 and 31.0 Ϯ 5.7 g/mL in the hemorrhagic shock and control groups, respectively).
The pharmacokinetic parameters of propofol in both groups are shown in Table 2 . In all animals, the correlation coefficients (r 2 ) were good for the two-and three-compartment models. However, the r 2 values in the two-compartment model (0.96 Ϯ 0.01 and 0.97 Ϯ 0.01 in the hemorrhagic shock and control groups, respectively) were slightly better than those in the three-compartment model (0.95 Ϯ 0.02 and 0.96 Ϯ 0.02, respectively), which may be because blood sampling for the measurements of propofol concentration was ended shortly after the start of propofol infusion (after 48 Ϯ 15 and 81 Ϯ 14 min, respectively). Therefore, the pharmacokinetic parameters were estimated using the two-compartment model. The volume of distribution in the central and peripheral compartments and the clearance were significantly lower in the hemorrhagic shock group.
Propofol infusion decreased BIS values in all animals and the propofol dose required to achieve a 50% decrease in the BIS value from baseline was significantly lower in the hemorrhagic shock group (133 Ϯ 31 mg) compared with the control group (246 Ϯ 56 mg). The corresponding mean infusion time in the hemorrhagic shock group (5 Ϯ 1 min) was significantly shorter than in the control group (10 Ϯ 2 min). A plot of BIS values against plasma propofol concentrations during and after propofol infusion showed a hysteresis loop in all animals. The hysteresis was collapsed by estimating the elimination constant from the effect site (k e0 ), resulting in the effect-site concentration-BIS effect relationship for propofol. The individual curves for all animals in both states are shown in Figure 2 . Correlations of BIS with the effect-site concentration were good in both states: the correlation coefficients (r 2 ) were 0.98 Ϯ 0.02 and 0.97 Ϯ 0.05 in the hemorrhagic shock and control groups, respectively. Hemorrhagic shock significantly shifted the The relationship between the responses to the dewclaw clamp (presence of movement ϭ 1, absence of movement ϭ 0) and plasma propofol concentrations during and after infusion of 50 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 propofol in a typical hemorrhagic shock animal is shown in Figure 3A . The plasma propofol concentration at which no movement was observed did not differ between the groups (25.7 Ϯ 5.3 and 29.1 Ϯ 6.5 g/mL in the hemorrhagic shock and control groups, respectively), but that at the return of movement was significantly lower in the hemorrhagic shock group (7.5 Ϯ 3.2 g/mL) compared with the control group (13.3 Ϯ 4.2 g/mL). The BIS values at which no movement was observed (5.8 Ϯ 9.7 and 8.1 Ϯ 13.0 in the hemorrhagic shock and control groups, respectively) and those at the return of movement (11.1 Ϯ 20.6 and 13.7 Ϯ 22.6, respectively) did not differ between the groups. The hysteresis was collapsed by estimating the elimination constant from the effect-site (k e0-immobility ), resulting in the effect-site concentrationimmobilizing effect relationship for propofol shown in Figure 3B . The logistic regression curves estimated using data from all animals by combining the individual plots in each state are shown in Figure 3C . Hemorrhagic shock significantly shifted the concentration probability of movement relationship to the left, with EC 50-immobility values of 20.6 Ϯ 1.0 and 26.8 Ϯ 1.0 g/mL in the hemorrhagic shock and control groups, respectively. A summary of pharmacodynamic variables in each group is shown in Table 3 . The elimination constant from the effect site of hypnosis (k e0 ) did not differ between the groups, but k e0-immobility was significantly higher in the hemorrhagic shock group.
DISCUSSION
Our results indicate that hemorrhagic shock increases the immobilizing effect of propofol and the hypnotic effect. To our knowledge, this is the first report showing an influence of hemorrhagic shock on immobilization by propofol. Previous reports have shown that hemorrhagic shock increases the hypnotic effect of propofol because of pharmacokinetic and pharmacodynamic alterations. 7, 8 Our results are consistent with these studies, and this study also indicates that hemorrhagic shock alters the immobilizing effect due to both pharmacokinetic and pharmacodynamic changes.
Johnson et al. 7 reported EC 50 values of 1.7 and 4.6 g/mL in hemorrhagic shock and control animals, respectively, in a swine study in which BIS was used to evaluate the hypnotic effect of propofol. These values are much lower than the values in this study (9.1 and 11.6 g/mL, respectively), perhaps because the hypnotic effect was investigated in the presence of 1 MAC isoflurane by Johnson et al. However, the extent of alteration is also clearly different, which may be because the shock level in our study was less severe due to a smaller volume of withdrawn blood and a smaller decrease in CO after hemorrhage. De Paepe et al. 8 found that the effect-site propofol concentration at the return of the righting reflex was 23% lower in hypovolemic rats compared with controls, and this finding is consistent with the decrease in the effect-site concentration in our work (22%). EC 50-immobility in hemorrhagic shock animals was approximately 23% less than that in controls, indicating a similar pharmacodynamic alteration in the immobilizing effect compared with the hypnotic effect. In our previous studies, we have examined the influence of hemorrhagic shock on the EEG effect 11, 12 and the MAC 14 of isoflurane. The alteration of the hypnotic effect was approximately 12% with hemorrhage at a level of 40% of the initial blood volume (28 mL/kg bleeding; the total volume was assumed to be 70 mL/kg), but MAC decreased from 2.05% Ϯ 0.28% to 1.50% Ϯ 0.51% (an approximately 25% decrease) even with hemorrhage at a level of 30% of the initial blood volume (21 mL/kg bleeding). In the MAC study, we used an isovolemic hemorrhage model and animals varied in their degree of metabolic compromise or compensation capacity in response to hemorrhagic shock, with the extent of the decrease in MAC correlating with the severity of the shock. In this study, we used an isobaric hemorrhage model and the total volume of withdrawn blood was 26.7 Ϯ 3.6 mL/kg; hence, the shock level was more severe and more consistent than that in the MAC study. In fact, the decreases in MAP and CO, and the increase in lactate in this study were higher than those in the MAC study. This suggests that if the hemorrhagic shock protocol had been applied in the previous work, MAC might have decreased to a greater extent than reported.
From these findings, we speculate that the increase in the immobilizing effect during hemorrhagic shock is greater for an inhaled anesthetic, compared with propofol. Propofol essentially causes immobility by a mechanism distinct from the actions of inhaled anesthetics. 22, 23 Using extracellular voltage recordings from ventral horn interneurons in cultured spinal cord tissue slices obtained from embryonic rats, Grasshoff and Antkowiak 22 demonstrated that the spinal actions of propofol involve ␥-aminobutyric acid Type A receptors almost exclusively (96%), whereas the effects of sevoflurane are mediated by glycine receptors (45%), ␥-aminobutyric acid Type A receptors (38%), and others (17%). The concentration-response relationships of anesthetic-induced depression of action potential firing rates of spinal neurons showed that sevoflurane exerts complete suppression of the mean discharge rate, whereas the effects of propofol reach an upper limit of approximately 60%, indicating that propofol has limited capacity in depressing action potential firing of spinal neurons. These findings suggest that the influence of hemorrhagic shock on the immobilizing effect in response to noxious stimuli does not necessarily occur to the same extent with propofol and inhaled anesthetics.
In our previous study, fluid resuscitation did not reverse the decrease in MAC during hemorrhagic shock, but additional administration of a -opioid antagonist did reverse the change in MAC, suggesting that activation of the endogenous opioid system explains the decrease in MAC during hemorrhagic shock. 14 In this study, endogenous opioid pathways must be activated, 24, 25 and therefore, we speculate that ␤-endorphin might be involved in the increase in the hypnotic and immobilizing potencies of propofol. However, De Paepe et al. 26 have demonstrated that the increase in hypnotic potency during hemorrhagic shock is not mediated by endogenous opioids in rats because the change in potency was not reversed by naloxone. Furthermore, some reports have suggested that the free fraction of propofol increases during hemorrhagic shock, especially when accompanied by aggressive fluid resuscitation, 27, 28 and that the increase in the free fraction of propofol (i.e., a pharmacokinetic change) might also be involved in the increase in propofol potency. Further investigations of the pharmacodynamic alterations of propofol during hemorrhagic shock are required to examine these mechanisms.
The k eo for hypnosis was higher than k eo-immobility in both states. The elimination constant from the effect site also estimates the onset effect, and the uptake and elimination of propofol in the spinal cord were slower than those in the cerebral cortex. Interestingly, hemorrhagic shock did not change k eo for hypnosis, which is consistent with previous reports 7,8 but significantly increased k eo-immobility . These findings suggest that hemorrhagic shock may quicken the uptake and elimination of propofol in the spinal cord, in contrast to the cerebral cortex. The mechanism is unclear, but the influence (or damage) of hemorrhagic shock on the spinal cord may differ from that in the cerebral cortex, although the pharmacodynamic change in the immobilizing effect is similar to that for the hypnotic effect.
Several limitations of this study need to be addressed. We used the BIS to evaluate the hypnotic effect of propofol in swine. Although the concentration versus effect plots demonstrated quite convincingly that BIS can be used for this purpose, there has been no formal validation of BIS for animal experiments. Furthermore, we applied the dewclaw clamp every 2 min during assessment of the hypnotic effect while waiting for a large decrease in the BIS value, and it is possible that painful stimuli might influence the concentration-hypnotic effect relationship due to an arousal reflex. In addition, we stopped inhalation of isoflurane, and the start of propofol infusion was delayed until observation of spontaneous movement. Furthermore, we confirmed that the end-tidal isoflurane concentration had decreased to Ͻ0.5% before administration of propofol because the presence of isoflurane influences the effects of propofol. However, we were unable to investigate the pharmacological effect of propofol in the complete absence of isoflurane for ethical reasons, and it is possible that the small amount of residual isoflurane might have had an influence on the results, even if it decreased over time.
Finally, there may be differences among species, and Vol. 109, No. 2, August 2009 the propofol dose required to produce EC 50 and EC 50-immobility in swine differed from those in humans. The influence of hemorrhagic shock on the two end points might be related to circulation and perfusion (including the presence or absence of autoregulation) in the spinal cord and cerebral cortex, and it is not certain that swine and humans are similar in this respect.
In summary, hemorrhagic shock increases both the immobilizing and hypnotic effects of propofol. Our results indicate that the extent of change in these effects during hemorrhagic shock is similar for propofol, in contrast to inhaled anesthetics that easily produce immobility with only a minimal change in hypnotic potency.
